This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Zemaira (Alpha 1-Antitrypsin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (57)
Death (1)
Reports by Reaction Type
Dyspnoea (13),
Infusion Related Reaction (12),
Dizziness (8),
Chills (7),
Fatigue (7),
Pneumonia (6),
Respiratory Tract Infection (6),
Chronic Obstructive Pulmonary Disease (5),
Upper Respiratory Tract Infection (5),
Sinusitis (5),
Condition Aggravated (5),
Bone Pain (4)
Below are a few examples of reports where side effects / adverse reactions may be related to Zemaira (Alpha 1-Antitrypsin). For a complete list or a specific selection of reports, please use the links above.
Possible Zemaira side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-15
Patient: female
Reactions: Respiratory Tract Infection
Drug(s) suspected as cause:
Zemaira
Possible Zemaira side effects in male
Reported by a physician from United States on 2012-08-15
Patient: male, weighing 113.4 kg (249.5 pounds)
Reactions: Dyspnoea, Chills, Blood Pressure Decreased, Hyperhidrosis, Hypertension, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Zemaira
Other drugs received by patient: Banophen (Diphenhydramine Hydrochloride); Centrum Ultra MEN (Centrm / 00554501 / ); Zyrtec; Hydrochlorothiazide; Celebrex; Lipitor; Lisinopril
Possible Zemaira side effects in 45 year old female
Reported by a pharmacist from United States on 2012-08-13
Patient: 45 year old female, weighing 104.3 kg (229.5 pounds)
Reactions: Tooth Loss, Weight Decreased, Anxiety, Dyspnoea, Vomiting, Nausea, Pulmonary Arterial Hypertension, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Dosage: (60 mg/kg 1x/week, 953 mg vial intravenous (not otherwise specified))
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2009-01-01
Zemaira
Dosage: (60 mg/kg 1x/week, 953 mg vial intravenous (not otherwise specified))
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2012-03-01
End date: 2012-03-01
Other drugs received by patient: Biotin; Xopenex; Singulair; Oxygen; Symbicort; Vitamin D; Digestive Probiotic (Lactobacillus Acidophilus); Alprazolam; Xanax; Protonix; Ipratropium Bromide; Albuterol; Codeine Sulfate; Combivent; Levothyroxine Sodium
Possible Zemaira side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-06
Patient: female
Reactions: Chills, Pyrexia, Device Related Infection
Drug(s) suspected as cause:
Zemaira
Aralast Alpha-1-Antitrypsin)
Start date: 2010-06-01
End date: 2010-08-01
Possible Zemaira side effects in male
Reported by a physician from United States on 2012-07-19
Patient: male
Reactions: Dizziness, Blood Glucose Increased
Drug(s) suspected as cause:
Zemaira
Other drugs received by patient: Spiriva; Darvocet-N 100; Robitussin DM (Robitussin); Zyrtec; Tylenol P (Paracetamol); Albuterol; Singulair; Lidoderm; Zetia; Advair HFA
Possible Zemaira side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient: male
Reactions: Lung Disorder, Dizziness, Unevaluable Event, Blood Glucose Increased
Drug(s) suspected as cause:
Zemaira
Possible Zemaira side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-06
Patient:
Reactions: Circumstance or Information Capable of Leading To Medication Error, Medication Error, Product Packaging Quantity Issue
Drug(s) suspected as cause:
Zemaira
Possible Zemaira side effects in 40 year old female
Reported by a pharmacist from United States on 2012-07-06
Patient: 40 year old female, weighing 59.0 kg (129.7 pounds)
Reactions: Product Colour Issue, Discomfort, Infusion Related Reaction
Drug(s) suspected as cause:
Zemaira
Possible Zemaira side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-02
Patient: female
Reactions: Chills, Device Related Infection, Pyrexia
Drug(s) suspected as cause:
Zemaira
Start date: 2010-08-01
Aralast NP
Start date: 2010-07-01
End date: 2010-08-01
Possible Zemaira side effects in 54 year old female
Reported by a physician from United States on 2012-05-29
Patient: 54 year old female, weighing 72.6 kg (159.7 pounds)
Reactions: Hospitalisation, Adverse Event
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Other drugs received by patient: Benadryl; Trazodone HCL; Multivitamin (Multivitamin / 00831701 / ); Lamictal; Sodium Chloride 0.9%; Fluoxetine
Possible Zemaira side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: female
Reactions: Chest Discomfort, Pneumonia, Dyspnoea, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Possible Zemaira side effects in 53 year old female
Reported by a consumer/non-health professional from United States on 2012-05-03
Patient: 53 year old female
Reactions: Hyperventilation, Dyspnoea, Paraesthesia
Drug(s) suspected as cause:
Zemaira
Possible Zemaira side effects in male
Reported by a physician from United States on 2012-04-23
Patient: male, weighing 97.5 kg (214.6 pounds)
Reactions: Vomiting, Nausea, Peritoneal Dialysis, Headache, Infusion Related Reaction
Drug(s) suspected as cause:
Zemaira
Indication: Alpha-1 Anti-Trypsin Deficiency
Zemaira
Dosage: 80 mg/kg 1x/week, 990 mg vial intravenous (not otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Zemaira
Indication: Alpha-1 Anti-Trypsin Deficiency
Zemaira
Dosage: 80 mg/kg 1x/week, 80 mg/kg weekly 15 minute total infusion time intravenous (not otherwise specifie
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2009-05-20
Other drugs received by patient: Cellcept; Folic Acid; Protonix; Amitriptyline HCL (Amitriptyline); Oxycodone HCL and Acetaminophen; Lantis (Insulin Glargine); BL Ferrous SU (Ferrous Sulfate); Prograff (Tacrolimus); Prochlorperazine; Prednisone; Calcium 600 D (Calcium with Vitamin D); Actos; Humalog; Lisinopril; Sodium Bicarbonate; Glipizide; Simvastatin
Possible Zemaira side effects in 61 year old female
Reported by a pharmacist from United States on 2012-04-02
Patient: 61 year old female, weighing 143.8 kg (316.3 pounds)
Reactions: Pneumonia, Cellulitis, Concomitant Disease Aggravated, Chronic Respiratory Failure, Chronic Obstructive Pulmonary Disease, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Dosage: (952 mg/vial; 952 mg/20 ml intravenous (not otherwise specified))
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2012-01-01
Zemaira
Dosage: (952 mg/vial; 952 mg/20 ml intravenous (not otherwise specified))
Indication: Emphysema
Start date: 2012-01-01
Zemaira
Dosage: (60 mg/kg 1x/week, 945 mg/vial;max rate=0.08 ml/kg/min (11.6 ml/min) intravenous (not otherwise spe
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2007-01-01
Zemaira
Dosage: (60 mg/kg 1x/week, 945 mg/vial;max rate=0.08 ml/kg/min (11.6 ml/min) intravenous (not otherwise spe
Indication: Emphysema
Start date: 2007-01-01
Zemaira
Indication: Emphysema
Start date: 2012-03-14
Zemaira
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2012-03-14
Other drugs received by patient: Sodium Chloride; Singulair; Vitamin D; Lasix; Prinzide; Cardizem; Zocor; Metformin HCL; Advair HFA; Ibuprofen (Advil); Multivitamin (Accomin Multivitamin); Ipratropium Albuterol (Salbutamol W / Ipratropium)
Possible Zemaira side effects in 54 year old female
Reported by a physician from United States on 2012-03-15
Patient: 54 year old female, weighing 78.9 kg (173.6 pounds)
Reactions: Productive Cough, Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Indication: Alpha-1 Anti-Trypsin Deficiency
Zemaira
Dosage: 60 mg/kg 1x/week, at rate of 0.08 ml per kg per minute intravenous (not otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2010-04-01
Zemaira
Dosage: 60 mg/kg 1x/week, 0.08 ml /kg/min intravenous (not otherwise specified))
Start date: 2012-02-28
Other drugs received by patient: Thiamine HCL; Pulmicort; Singulair; Multivitamin (Daily Multivitamin); Foradil; Albuterol; Protonix; Zaroxolyn; Heparin; Nexium; Prednisone TAB; Lasix (Insulin Glargine); Diltiazem HCL; Lantus; Flexeril; Spiriva; Vitamin B12 (Cyanocobalamin-Tannin Complex); Digoxin; Doxycycline
Possible Zemaira side effects in 54 year old female
Reported by a pharmacist from United States on 2012-03-14
Patient: 54 year old female, weighing 72.6 kg (159.7 pounds)
Reactions: Hospitalisation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Other drugs received by patient: Trazodone HCL; Benadryl; Fluoxetine; Sodium Chloride; Multi-Vitamin; Lamictal
Possible Zemaira side effects in 58 year old female
Reported by a pharmacist from United States on 2012-03-14
Patient: 58 year old female, weighing 82.0 kg (180.4 pounds)
Reactions: Cellulitis, Sinusitis, Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Dosage: intravenous (not otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-06-01
Zemaira
Dosage: 60 mg/kg 1x/week intravenous otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Zemaira
Dosage: 60 mg/kg 1x/week intravenous (not otherwise specified,
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2007-02-01
Zemaira
Dosage: intravenous (not otherwise specified
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-04-01
Zemaira
Dosage: 869 mg vial; max rate of 0.08 ml./kg/min (3 ml/min) intravenous (not otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Zemaira
Dosage: 60 mg/kg 1x/week
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2007-01-01
Other drugs received by patient: Oxygen; Aspirin; Lutein (Xantofyl); Fosamax; Prednisone; Azmacort Inhaler (Triamcinolone Acetonide); Xanax; Sodium Chloride; Albuterol; Ibuprofen; Multivitamin (Accomin Multivitamin); Spiriva; Acetaminophen; Pneumovax 23; Doxycycline Hyclate
Possible Zemaira side effects in 49 year old female
Reported by a pharmacist from United States on 2012-03-14
Patient: 49 year old female, weighing 62.6 kg (137.7 pounds)
Reactions: Fatigue, Upper Respiratory Tract Infection, Pulmonary Arterial Hypertension, Somnolence, Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Dosage: 60 mg/kg 1x/7 days intravenous (not otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2009-11-01
Zemaira
Dosage: intravenous (not otherwise specified))
Indication: Alpha-1 Anti-Trypsin Deficiency
Other drugs received by patient: Sodium Chloride; Doxepin HCL; Xopenex HFA (Levosalbutamol); Zyban; Estradiol; Lisinopril; Oxygen; Spiriva; Prednisone TAB; Advair 250 (Seretide); Albuterol
Possible Zemaira side effects in male
Reported by a pharmacist from United States on 2012-03-02
Patient: male, weighing 73.5 kg (161.7 pounds)
Reactions: Asthma, Respiratory Tract Congestion, Chest Pain, Oxygen Saturation Decreased
Drug(s) suspected as cause:
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2010-01-01
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2010-01-01
Zemaira
Other drugs received by patient: Zyrtec; Singulair; Sodium Chloride 0.9%; Prednisone TAB; Flovent; Spiriva; Nasacort; Levaquin
Possible Zemaira side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15
Patient: 58 year old female, weighing 82.0 kg (180.4 pounds)
Reactions: Cellulitis, Skin Infection, Respiratory Tract Infection, Sinusitis
Drug(s) suspected as cause:
Zemaira
Dosage: 60;869;0.08; 3mg 1xweek, intravenous
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-04-01
Zemaira
Dosage: 60;869;0.08; 3mg 1xweek, intravenous
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2007-02-01
Zemaira
Dosage: 60;869;0.08; 3mg 1xweek, intravenous
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-06-01
Zemaira
Dosage: 60;869;0.08; 3mg 1xweek, intravenous
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2007-01-01
Zemaira
Zemaira
Other drugs received by patient: Fosamax; Prednisone TAB; Albuterol; Xanax; Pneumovax 23; Ibuprofen; Multivitamin (Accomin Multivitamin); Azmacort Inhaler (Triamcinolone Acetonide; Lutein (Xantofyl); Oxygen (Oxygen); Spiriva; Acetaminophen; Aspirin; Sodium Chloride 0.9%
Possible Zemaira side effects in 61 year old female
Reported by a pharmacist from United States on 2012-02-15
Patient: 61 year old female, weighing 144.7 kg (318.3 pounds)
Reactions: Pneumonia, Cellulitis, Condition Aggravated, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemaira
Zemaira
Dosage: 60 mg/kg 1/week, 945 mg/vial, max rate = 0.08 ml/kg/min (11.6 ml /min intravenous (not otherwise spe
Indication: Emphysema
Zemaira
Dosage: 60 mg/kg 1/week, 945 mg/vial, max rate = 0.08 ml/kg/min (11.6 ml /min intravenous (not otherwise spe
Indication: Alpha-1 Anti-Trypsin Deficiency
Other drugs received by patient: Sodium Chloride 0.9%; Singulair; Cardizem; Oxygen (Oxygen); Ibuprofen (Advil); Lasix; Advair HFA; Multivitamin (Accomin Multivitamin); Vitamin D; Ipratropium Albuterol (Salbutamol W / Ipratropium); Zocor; Metformin HCL; Prinzide
Possible Zemaira side effects in 56 year old female
Reported by a physician from United States on 2012-01-23
Patient: 56 year old female, weighing 72.6 kg (159.7 pounds)
Reactions: Respiratory Tract Congestion, Viral Upper Respiratory Tract Infection, Nasopharyngitis, Condition Aggravated, Sinusitis, Chronic Obstructive Pulmonary Disease, Lower Respiratory Tract Infection
Drug(s) suspected as cause:
Zemaira
Dosage: see image
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-10-13
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-10-13
Zemaira
Dosage: see image
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2012-01-05
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2012-01-05
Zemaira
Dosage: see image
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2009-08-01
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2009-08-01
Zemaira
Zemaira
Zemaira
Other drugs received by patient: Mucinex; Singulair; Lisinopril; Advair Diskus 100 / 50; Lexapro; Estrace; PRO AIR (Procaterol Hydrochloride); Prinivil; Spiriva; Activella (Oestranorm)
Possible Zemaira side effects in 61 year old female
Reported by a physician from United States on 2012-01-23
Patient: 61 year old female, weighing 91.2 kg (200.6 pounds)
Reactions: Contusion, Angioedema, Pain in Extremity, Condition Aggravated, Nasal Congestion, Musculoskeletal Chest Pain, Headache, Oral Pruritus, Fall, Oral Discomfort, Pruritus Generalised, Fatigue, Limb Injury, Dizziness, Infusion Related Reaction
Drug(s) suspected as cause:
Zemaira
Zemaira
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-01-26
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-01-26
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-03-31
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-03-31
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-02-20
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-02-20
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-05-05
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-05-05
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-01-28
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-01-28
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2011-01-26
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2011-01-26
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2010-11-01
Zemaira
Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2010-11-01
Zemaira
Zemaira
Zemaira
Other drugs received by patient: Novolog; Protonix; Sodium Chloride 0.9%; Ibuprofen; Xanax; Levothyroxine Sodium; Vitamin B12; Novolog; Celexa; Lantus; Atenolol; Albuterol; Multivitamin (Accomin Multivitamin); Vitamin D; Gabapentin; Cardizem
Possible Zemaira side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-20
Patient: male, weighing 110.0 kg (242.0 pounds)
Reactions: Chest Discomfort, Pharyngeal Disorder, Dizziness, Headache, Infusion Related Reaction
Drug(s) suspected as cause:
Zemaira
Other drugs received by patient: Ascorbic Acid; Losartan Potassium; Symbicort; Combivent; PRE MED Benadril; Amlodipine
Possible Zemaira side effects in 56 year old female
Reported by a physician from United States on 2012-01-18
Patient: 56 year old female, weighing 72.6 kg (159.7 pounds)
Reactions: Upper Respiratory Tract Infection, Sinusitis
Drug(s) suspected as cause:
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2009-08-01
Zemaira
Dosage: see image
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2009-08-01
Zemaira
Zemaira
Zemaira
Other drugs received by patient: Singulair; PRO AIR (Procaterol Hydrochloride); Advair HFA; Prinivil; Mucinex; Lexapro; Spiriva; Activella (Oestranorm); Estrace; Lisinopril
Possible Zemaira side effects in 68 year old female
Reported by a pharmacist from United States on 2012-01-18
Patient: 68 year old female, weighing 66.2 kg (145.7 pounds)
Reactions: Vomiting, Nausea, Lower Respiratory Tract Infection, Infusion Related Reaction
Drug(s) suspected as cause:
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2010-11-22
Zemaira
Dosage: see image
Indication: Emphysema
Start date: 2010-11-22
Zemaira
Start date: 2010-11-22
Zemaira
Start date: 2010-11-22
Other drugs received by patient: Calan; Benzonatate; Xanax; Advair HFA; Orphenadrine Citrate; Zyrtec; Pravastatin; Lyrica; Avapro; Maxzide; Oxygen; Multivitamin Accomin Multivitamin); Sodium Chloride; Albuterol
Possible Zemaira side effects in 50 year old female
Reported by a pharmacist from United States on 2012-01-18
Patient: 50 year old female, weighing 45.4 kg (99.8 pounds)
Reactions: Lung Infection
Drug(s) suspected as cause:
Zemaira
Dosage: (60 mg/kg 1x/week,869 mg/20 ml vial;0.08 ml/kg/min(3.7 ml/min.) intravenous(not otherwise specified)
Indication: Blood Disorder
Start date: 2005-04-01
Zemaira
Dosage: (60 mg/kg 1x/week,869 mg/20 ml vial;0.08 ml/kg/min(3.7 ml/min.) intravenous(not otherwise specified)
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2005-04-01
Other drugs received by patient: Sodium Chloride; Heparin; Symbicort; Albuterol; Oxygen; Protonix; Vitamin D; Aspirin; Spiriva; Singulair
Possible Zemaira side effects in 74 year old female
Reported by a physician from United States on 2012-01-12
Patient: 74 year old female, weighing 69.9 kg (153.7 pounds)
Reactions: Pruritus, Urticaria, Rash, Kidney Infection
Drug(s) suspected as cause:
Zemaira
Zemaira
Dosage: see image
Indication: Alpha-1 Anti-Trypsin Deficiency
Start date: 2007-05-21
Zemaira
Dosage: see image
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2007-05-21
Other drugs received by patient: Prednisone TAB; Evista; Lorazepam; Doxepin HCL; Theo-24 ER (Theophylline); Allegra; Multivitamin (Accomin Multivitamin); Pataday (Olopatadine Hydrochloride); Lisinopril; Qvar 40; Kenalog; Potassium Chloride; Furosemide; Actonel; Albuterol; Calcium Carbonate; Heparin; Prevacid; Theratears (Carmellose)
Possible Zemaira side effects in 56 year old male
Reported by a physician from United States on 2012-01-06
Patient: 56 year old male, weighing 70.3 kg (154.7 pounds)
Reactions: Myalgia, Syncope, Bone Pain, Dizziness, Feeling Abnormal, Chest X-RAY Abnormal, Loss of Consciousness, Infusion Related Reaction
Drug(s) suspected as cause:
Zemaira
Zemaira
Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
Indication: Obstructive Airways Disorder
Start date: 2011-03-25
Zemaira
Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
Indication: Obstructive Airways Disorder
Start date: 2011-11-04
End date: 2011-11-04
Zemaira
Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
Indication: Obstructive Airways Disorder
Start date: 2011-01-01
Zemaira
Other drugs received by patient: Symbicort; Daliresp; Spiriva; Proventil; Mucinex
Possible Zemaira side effects in male
Reported by a physician from United States on 2011-12-28
Patient: male, weighing 113.4 kg (249.5 pounds)
Reactions: Dyspnoea, Chills, Hypertension, Hyperhidrosis
Drug(s) suspected as cause:
Zemaira
Other drugs received by patient: Centrum Ulta MEN (Centrum / 00554501 / ); Lisinopril; Lipitor (Atorvastain Calcium); Celebrex (Celeboxib); Hydrochlorothiazide; Zyrtec; Banophen (Diphenhydramine Hydrochloride)
|